Epilepsy
1,349
177
212
755
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
262 trials with published results (19%)
Research Maturity
755 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.4%
86 terminated out of 1349 trials
89.8%
+3.2% vs benchmark
18%
249 trials in Phase 3/4
35%
262 of 755 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 755 completed trials
Clinical Trials (1349)
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Safety and Efficacy of tPBM for Epileptiform Activity in Autism
OASIS: RetrOspective Analysis on EEGs for Identifying Seizure Susceptibility in paediatrIcs Using biomarkerS
HOBSCOTCH-YOUTH and Young Adults
Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)
Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
Surgery as a Treatment for Medically Intractable Epilepsy
Cognitive Enhancement Intervention for Creating a Healthy L.I.F.E (Lifestyle Interventions for Epilepsy)
A Device to Prevent Sudden Unexpected Death in Epilepsy: Detecting Peri-Ictal Body Position
A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy
Human Cognition During Surgery: Stimulation-based and Cholinergic Modulation
Lily's Grace Temporal Interference
Risk Factors for Drug-Resistant Epilepsy in Children
AI-enhanced LF-MRI in Epilepsy
Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy
Retinal OCT Changes and Biomarkers in Drug-Resistant Epilepsy